| TGFβ signal converter |
2023-4-12 |
2023-6-27 |
|
| Multipartite receptor and signaling complexes |
2023-4-07 |
2023-10-12 |
|
| Muc16 chimeric antigen receptors |
2023-1-10 |
2023-10-19 |
|
| Methods for making t cell compositions |
2022-12-20 |
2023-6-22 |
|
| Methods and compositions for modulating the activity of a dimerizing agent … |
2022-12-09 |
2023-8-31 |
|
| Multipartite signaling proteins and uses thereof |
2022-11-10 |
2023-9-14 |
|
| Donor repair templates multiplex genome editing |
2022-10-21 |
2023-6-08 |
|
| Cblb endonuclease variants, compositions, and methods of use |
2022-10-18 |
2022-12-08 |
|
| Mnd promoter chimeric antigen receptors |
2022-9-21 |
2022-11-01 |
|
| Vector manufacturing processes |
2022-7-19 |
2023-1-26 |
|
| Engineered t cell receptors fused to binding domains from antibodies |
2022-7-14 |
2023-1-19 |
|
| Anti-BCMA CAR T cell compositions |
2022-6-17 |
2022-8-04 |
|
| Single stranded rna purification methods |
2022-6-14 |
2022-12-22 |
|
| Pd-1 homing endonuclease variants, compositions, and methods of use |
2022-5-06 |
2022-10-27 |
|
| Bcma chimeric antigen receptors |
2022-4-25 |
2022-6-16 |
|
| Tgfbetar2 endonuclease variants, compositions and methods of use |
2022-4-14 |
2022-7-07 |
|
| Dimerizing agent regulated immunoreceptor complexes |
2022-3-27 |
2022-5-01 |
|
| Improved methods for manufacturing adoptive cell therapeutics |
2022-1-18 |
2022-3-10 |
|
| Compositions and methods for site-directed mutagenesis |
2021-12-16 |
2023-8-22 |
|
| Compositions and methods for treating cancer |
2021-12-12 |
2022-2-01 |
|
| gene-modified t cells |
2021-12-02 |
2022-4-08 |
|
| Cd33 targeted immunotherapies |
2021-11-09 |
2022-5-12 |
|
| Aml targeted immunotherapies |
2021-11-09 |
2022-5-12 |
|
| Cd33 targeted immunotherapies |
2021-11-01 |
2022-1-01 |
|
| Cll-1 targeted immunotherapies |
2021-11-01 |
2022-1-01 |
|
| mage a4 t cell receptors |
2021-9-24 |
2022-6-10 |
|
| Bcma chimeric antigen receptors |
2021-8-24 |
2023-10-05 |
|
| Methods for manufacturing viral vectors |
2021-6-10 |
2021-12-16 |
|
| Modified CCR polypeptides and uses thereof |
2021-4-16 |
2022-11-17 |
|
| Frb antibodies |
2021-4-09 |
2021-10-14 |
|
| T cell receptor |
2021-3-26 |
2022-12-05 |
|
| Cblb endonuclease variants, compositions, and methods of use |
2021-1-15 |
2021-7-15 |
|
| Anti-bcma car antibodies, conjugates, and methods of use |
2020-12-16 |
2022-10-26 |
|
| CD123 targeted immunotherapies |
2020-5-07 |
2022-1-06 |
|
| Preparation of anti-BCMA CAR T cells |
2020-4-02 |
2022-3-11 |
|
| Adoptive cell therapy |
2020-3-20 |
2022-11-17 |
|
| Methods and systems for manufacturing viral vectors |
2020-1-22 |
2021-8-12 |
|
| Dimerizing agent regulated immunoreceptor complexes |
2019-12-13 |
2020-6-18 |
|
| Dimerizing agent regulated immunoreceptor complexes |
2019-12-13 |
2022-10-26 |
|
| Dimerizing agent regulated immunoreceptor complexes |
2019-12-13 |
2022-1-27 |
|
| PDCD-1 homing endonuclease variants |
2019-12-09 |
2021-6-24 |
|
| Homing endonuclease variants |
2019-12-09 |
2021-6-24 |
|
| Cell therapy vessels |
2019-11-06 |
2022-1-06 |
|
| Bcma chimeric antigen receptors |
2019-7-18 |
2020-3-12 |
|
| Cd79a chimeric antigen receptors |
2019-6-14 |
2022-3-02 |
|
| Cd79b chimeric antigen receptors |
2019-6-14 |
2022-3-02 |
|
| Anti-bcma car antibodies, conjugates, and methods of use |
2019-6-14 |
2021-5-05 |
|
| Adoptive cellular therapy |
2019-4-12 |
2021-8-19 |
|
| Multivalent chimeric antigen receptor |
2018-12-21 |
2022-7-14 |
|
| Ctla4 homing endonuclease variants, compositions, and methods of use |
2018-12-20 |
2021-1-07 |
|
| Daric interleukin receptors |
2018-12-14 |
2021-9-01 |
|
| Nkg2d daric receptors |
2018-12-14 |
2021-8-05 |
|
| Pcsk9 endonuclease variants, compositions, and methods of use |
2018-10-04 |
2020-12-03 |
|
| Donor repair templates multiplex genome editing |
2018-2-15 |
2023-11-01 |
2023-11-01 |
| Vcn enhancer compositions and methods of using the same |
2018-2-09 |
2019-12-18 |
|
| Light string with multiple movable clips |
2017-11-03 |
2019-10-17 |
|
| TCRa HOMING ENDONUCLEASE VARIANTS |
2017-10-11 |
2019-9-11 |
|
| Tim3 homing endonuclease variants, compositions, and methods of use |
2017-8-23 |
2019-7-03 |
|
| Genome editing enhancers |
2017-8-18 |
2019-6-06 |
|
| Il-10 receptor alpha homing endonuclease variants, compositions, and methods of … |
2017-8-15 |
2018-2-22 |
|
| Salvage chimeric antigen receptor systems |
2017-4-14 |
2019-12-04 |
|
| Chimeric antigen receptor t cell compositions |
2017-4-07 |
2019-5-30 |
|
| Genome edited immune effector cells |
2017-3-10 |
2022-4-19 |
|
| T cell compositions |
2015-12-07 |
2022-10-25 |
2022-10-25 |
| LAGLIDADG homing endonuclease cleaving the T cell receptor alpha gene and uses … |
2014-5-28 |
2018-6-19 |
2018-6-19 |
| Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) … |
2014-5-28 |
2018-6-26 |
2018-6-26 |
| Spenderreparaturtemplates für multiplex-genomeditierung |
2018-2-15 |
2023-11-01 |
2023-11-01 |
| Modèles de réparation de donneur pour l'édition de génome multiplex |
2018-2-15 |
2023-11-01 |
2023-11-01 |